Home

Biotech

Broadband

B2B Internet

Europe 2001

Internet

Internet 
Architecture

Internet 
Infrastructure

Market 2000+

Oil Services

Pharmaceutical

Regional Bank

Retail

Semiconductor

Software

Telecom

Utilities

Wireless
ImmunoGen Inc (NASDAQ GM:IMGN)9/3/2010
most recent headlinesmore headlines:       
THURSDAY, SEPTEMBER 02, 2010
6:30 AMImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in September - BusinessWire
FRIDAY, AUGUST 27, 2010
6:01 AMGenentech Receives Refuse to File Letter from FDA for T-DM1 - BusinessWire
THURSDAY, AUGUST 19, 2010
5:33 AMImmunoGen Inc secures orphan drug designation for lorvotuzumab mertansine for small-cell lung cancer - M2
WEDNESDAY, AUGUST 18, 2010
12:45 PMImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer - BusinessWire
WEDNESDAY, AUGUST 04, 2010
4:01 PMImmunoGen, Inc. Reports Fourth Quarter and Fiscal Year 2010 Financial Results - BusinessWire
THURSDAY, JULY 29, 2010
6:30 AMImmunoGen, Inc. Announces Webcast of Presentation at Upcoming Investor Conferences - BusinessWire
WEDNESDAY, JULY 28, 2010
6:30 AMImmunoGen, Inc. Announces Conference Call to Discuss its Fourth Quarter and Fiscal Year 2010 Financial Results - BusinessWire
THURSDAY, JUNE 24, 2010
4:03 PMImmunoGen, Inc. Earns Milestone with Start of SAR650984 Clinical Trial - BusinessWire
TUESDAY, JUNE 22, 2010
3:02 PMImmunoGen, Inc. Announces Vice President Promotions in Product Development - BusinessWire
MONDAY, JUNE 07, 2010
9:02 AMImmunoGen, Inc. Announces Encouraging IMGN388 Clinical Data Reported at ASCO - BusinessWire


Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

HOLDRS Defined |  HOLDRS Outstanding  |  FAQ  |  Proxies by email  |  Investment Strategies
Spin-Offs & Changes  |  Current Trading  |  Download a Prospectus  |  Site Map

Merrill Lynch, Pierce, Fenner & Smith Incorporated is a registered broker-dealer and a wholly-owned subsidiary of Bank of America Corporation.
Securities Products: Are Not FDIC Insured • Are Not Bank Guaranteed • May Lose Value.

The information in this Internet site is directed at, and is intended for distribution to, and for use by, persons in the U.S. only, and is not intended for distribution to or use by any person in any other jurisdiction. Merrill Lynch does not warrant the accuracy or completeness of any price, tax, cost basis, or other information on this site, or any investment, tax or other benefits associated with HOLDRS.

The information on HOLDRSSM contained in this Internet site is solely for informational purposes and does not constitute either an offer to sell or the solicitation of an offer to buy HOLDRS. This information on HOLDRS is not, and is not intended to be, a complete discussion of all material information you should know about HOLDRS. If you are considering whether to purchase a HOLDRS security, you should carefully read the relevant prospectus prior to making a purchase. You should not rely on the information contained in this Internet site. Please view Terms of Use and Legal Notices for additional important legal information and the terms and conditions governing your use of this site.

U.S. Patent Pending.
HOLDRS and HOLding Company Depositary ReceiptS are service marks of Merrill Lynch & Co., Inc.

© Copyright 2000, Merrill Lynch, Pierce, Fenner & Smith Incorporated. Member, Securities Investor Protection Corporation (SIPC). All rights reserved.